Q1 earnings are due to be out on Monday, April 28. As of writing, that’s less than 24 hours away. Analysts expect a modest ...

Very large US-based firms now dominate in global profits. Yet this has not translated into productive investment rates in the ...

Wall Street bosses are thought to have suggested that only by firing Navarro, can some semblance of normality return.

MerckMRK reported its first-quarter 2025 results last week, beating estimates for both earnings and sales. Adjusted earnings ...

Launched on 05/01/2006, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity ...

Donald Trump is nearing the 100-day mark of his second presidency and investors are no closer to figuring out how to trade ...

Verizon’s 5G growth and Bristol Myers Squibb’s innovation both provide strong income and growth prospects. Read more on BMY ...

Electronics manufacturing services company Sanmina (NASDAQ:SANM) reported Q1 CY2025 results beating Wall Street’s revenue ...

Indivior PLC’s recovery hinges on Sublocade’s momentum and market trends, though risks persist in litigation and earnings.

An AP-NORC poll finds many Americans don't agree with Trump’s aggressive efforts to enact his agenda, and even Republicans ...

Approval of Lynozyfic is based on data showing deep and durable responses in relapsed/refractory multiple myeloma Lynozyfic will provide a new option with convenient dosing and administration to patie ...